Alkem Laboratories has approved the initiation of a forensic audit following an incident involving alleged misappropriation of funds by a former employee. The audit, conducted by Grant Thornton Bharat LLP, aims to examine the facts and circumstances, determine the root cause, and recommend corrective measures. This disclosure is made in compliance with SEBI regulations, signaling a commitment to transparency and accountability in addressing the alleged irregularities.
Forensic Audit Greenlit by Audit Committee
Alkem Laboratories Limited announced today, October 21, 2026, that its Audit Committee has approved the commencement of a forensic audit. This decision stems from a recent incident involving allegations of misappropriation of funds by a former employee of the company.
Objective and Scope of the Audit
The primary objective of this forensic audit is to meticulously examine the facts and circumstances surrounding the alleged incident. Grant Thornton Bharat LLP has been appointed to conduct this investigation. The audit will focus on determining the root cause of the alleged misappropriation and subsequently recommend appropriate corrective measures to prevent recurrence. The scope includes assisting in performing a preliminary electronically stored information (ESI) review and market intelligence over procurement done by the former employee, alongside an independent investigation into suspected irregularities in certain transactions affecting the company.
Commitment to Transparency
This disclosure is made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Alkem Laboratories has committed to making a copy of this disclosure available on its website, underscoring its dedication to transparency and adherence to regulatory requirements. The company aims to ascertain all facts and circumstances related to the incident and implement necessary actions.
Source: BSE
